CareDx to Participate in Upcoming Investor Conference
September 21 2018 - 8:00AM
CareDx, Inc. (NASDAQ: CDNA), a molecular diagnostics company
focused on the discovery, development and commercialization of
clinically differentiated, high-value diagnostic solutions for
transplant patients, today announced that Peter Maag, Chief
Executive Officer, and Michael Bell, Chief Financial Officer, will
be participating in the Cantor Fitzgerald Global Healthcare
Conference, to be held October 1-3, 2018 in New York, NY. The
company is scheduled to present on Tuesday, October 2, 2018 at 3:25
PM ET.
A live audio webcast of the Cantor Fitzgerald Global Healthcare
Conference presentation will be available online from the investor
relations section of the CareDx website at
https://investors.caredxinc.com/. The webcast replay of the
presentation will be available approximately one hour following the
conclusion of the live presentation and will be available on the
Company’s website for 90 days.
About CareDx CareDx,
Inc., headquartered in Brisbane, California, is a molecular
diagnostics company focused on the discovery, development and
commercialization of clinically differentiated, high-value
diagnostic solutions for transplant recipients. CareDx offers
products along the pre- and post-transplant testing continuum.
For more information, please visit: www.CareDx.com.
CONTACTS:
Investor RelationsDavid ClairIntegrated Corporate Relations,
Inc.646-277-1266david.clair@icrinc.com
CareDx (NASDAQ:CDNA)
Historical Stock Chart
From Mar 2024 to Apr 2024
CareDx (NASDAQ:CDNA)
Historical Stock Chart
From Apr 2023 to Apr 2024